Literature DB >> 24861823

Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source.

Youyong Yuan1, Jie Liu, Bin Liu.   

Abstract

Nanomaterials that combine diagnostic and therapeutic functions within a single nanoplatform are highly desirable for molecular medicine. Herein we report a novel theranostic platform based on a conjugated-polyelectrolyte (CPE) polyprodrug that contains functionality for image, chemo- and photodynamic therapy (PDT), and on-demand drug release upon irradiation with a single light source. Specifically, the PEGylated CPE serves as a photosensitizer and a carrier, and is covalently conjugated to doxorubicin through a linker that can be cleaved by reactive oxygen species (ROS). Under appropriate light irradiation, the CPE can generate ROS, not only for PDT, but also for on-demand drug release and chemotherapy. This nanoplatform will offer on-demand PDT and chemotherapy with drug release triggered by one light switch, which has great potential in cancer treatment.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  conjugated polyelectrolytes; drug delivery; image-guided therapy; nanotechnology; photodynamic therapy

Mesh:

Substances:

Year:  2014        PMID: 24861823     DOI: 10.1002/anie.201402189

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  40 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

Review 2.  Prodrug strategies for targeted therapy triggered by reactive oxygen species.

Authors:  Jorge Peiró Cadahía; Viola Previtali; Nikolaj S Troelsen; Mads H Clausen
Journal:  Medchemcomm       Date:  2019-05-08       Impact factor: 3.597

3.  ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy.

Authors:  Xiaoding Xu; Phei Er Saw; Wei Tao; Yujing Li; Xiaoyuan Ji; Sushant Bhasin; Yanlan Liu; Dana Ayyash; Jonathan Rasmussen; Marc Huo; Jinjun Shi; Omid C Farokhzad
Journal:  Adv Mater       Date:  2017-07-06       Impact factor: 30.849

Review 4.  Strategies to Improve Photodynamic Therapy Efficacy of Metal-Free Semiconducting Conjugated Polymers.

Authors:  Na Sun; Xue Wen; Song Zhang
Journal:  Int J Nanomedicine       Date:  2022-01-19

5.  Synthesis of a reactive oxygen species responsive heterobifunctional thioketal linker.

Authors:  Xiaoxi Ling; Shaojuan Zhang; Pin Shao; Pengcheng Wang; Xiaochao Ma; Mingfeng Bai
Journal:  Tetrahedron Lett       Date:  2015-09-09       Impact factor: 2.415

6.  Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy.

Authors:  Chenggen Qian; Jicheng Yu; Yulei Chen; Quanyin Hu; Xuanzhong Xiao; Wujin Sun; Chao Wang; Peijian Feng; Qun-Dong Shen; Zhen Gu
Journal:  Adv Mater       Date:  2016-03-07       Impact factor: 30.849

Review 7.  Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles.

Authors:  Homan Kang; Shrutika Mintri; Archita Venugopal Menon; Hea Yeon Lee; Hak Soo Choi; Jonghan Kim
Journal:  Nanoscale       Date:  2015-11-03       Impact factor: 7.790

8.  A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.

Authors:  Chen Xu; Rijin Song; Pei Lu; Jianchun Chen; Yongqiang Zhou; Gang Shen; Minjun Jiang; Wei Zhang
Journal:  Int J Nanomedicine       Date:  2020-01-08

9.  Cascade Drug-Release Strategy for Enhanced Anticancer Therapy.

Authors:  Xu Zhang; Sheng Wang; Guohui Cheng; Peng Yu; Jin Chang; Xiaoyuan Chen
Journal:  Matter       Date:  2021-01-06

10.  Photodynamic-Chemodynamic Cascade Reactions for Efficient Drug Delivery and Enhanced Combination Therapy.

Authors:  Sheng Wang; Guocan Yu; Weijing Yang; Zhantong Wang; Orit Jacobson; Rui Tian; Hongzhang Deng; Lisen Lin; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2021-04-08       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.